Author

Lorenzo Bertani

ONE YEAR OF USTEKINUMAB THERAPY IMPROVES NUTRITIONAL STATUS IN PATIENTS WITH CROHN’S DISEASE
ONE YEAR OF USTEKINUMAB THERAPY IMPROVES NUTRITIONAL STATUS IN PATIENTS WITH CROHN’S DISEASE

BASELINE IL-23 SERUM LEVELS PREDICT THERAPEUTIC RESPONSE TO USTEKINUMAB THERAPY IN CROHN'S DISEASE. A PROSPECTIVE STUDY
BASELINE IL-23 SERUM LEVELS PREDICT THERAPEUTIC RESPONSE TO USTEKINUMAB THERAPY IN CROHN'S DISEASE. A PROSPECTIVE STUDY

ADHERENCE TO MESALAZINE AND IDENTIFICATION OF PATIENTS WITH ULCERATIVE COLITIS IN HEALTHCARE ADMINISTRATIVE DATABASES OF TUSCANY (ITALY)
ADHERENCE TO MESALAZINE AND IDENTIFICATION OF PATIENTS WITH ULCERATIVE COLITIS IN HEALTHCARE ADMINISTRATIVE DATABASES OF TUSCANY (ITALY)

DIAGNOSTIC DELAY, EFFECTIVENESS AND SAFETY OUTCOMES IN A REAL-WORLD COHORT OF PATIENTS WITH CROHN'S DISEASE: DATA FROM ADMINISTRATIVE DATABASES IN TUSCANY, ITALY
DIAGNOSTIC DELAY, EFFECTIVENESS AND SAFETY OUTCOMES IN A REAL-WORLD COHORT OF PATIENTS WITH CROHN'S DISEASE: DATA FROM ADMINISTRATIVE DATABASES IN TUSCANY, ITALY

BASELINE IL-23 SERUM LEVELS PREDICT THERAPEUTIC RESPONSE TO USTEKINUMAB THERAPY IN CROHN'S DISEASE. A PROSPECTIVE STUDY
BASELINE IL-23 SERUM LEVELS PREDICT THERAPEUTIC RESPONSE TO USTEKINUMAB THERAPY IN CROHN'S DISEASE. A PROSPECTIVE STUDY

Lorenzo Bertani  et al.

ONE YEAR OF USTEKINUMAB THERAPY IMPROVES NUTRITIONAL STATUS IN PATIENTS WITH CROHN’S DISEASE
ONE YEAR OF USTEKINUMAB THERAPY IMPROVES NUTRITIONAL STATUS IN PATIENTS WITH CROHN’S DISEASE

Lorenzo Bertani  et al.

DIAGNOSTIC DELAY, EFFECTIVENESS AND SAFETY OUTCOMES IN A REAL-WORLD COHORT OF PATIENTS WITH CROHN’S DISEASE: DATA FROM ADMINISTRATIVE DATABASES IN TUSCANY, ITALY
DIAGNOSTIC DELAY, EFFECTIVENESS AND SAFETY OUTCOMES IN A REAL-WORLD COHORT OF PATIENTS WITH CROHN’S DISEASE: DATA FROM ADMINISTRATIVE DATABASES IN TUSCANY, ITALY

Lorenzo Bertani  et al.

ADHERENCE TO MESALAZINE AND IDENTIFICATION OF PATIENTS WITH ULCERATIVE COLITIS IN HEALTHCARE ADMINISTRATIVE DATABASES OF TUSCANY (ITALY)
ADHERENCE TO MESALAZINE AND IDENTIFICATION OF PATIENTS WITH ULCERATIVE COLITIS IN HEALTHCARE ADMINISTRATIVE DATABASES OF TUSCANY (ITALY)

Lorenzo Bertani  et al.

BIOLOGIC AGENTS IN IBD PATIENTS AFTER SOLID ORGAN TRANSPLANTATION DO NOT INCREASE THE RATES OF INFECTION OR ADVERSE EVENTS
BIOLOGIC AGENTS IN IBD PATIENTS AFTER SOLID ORGAN TRANSPLANTATION DO NOT INCREASE THE RATES OF INFECTION OR ADVERSE EVENTS

Lorenzo Bertani  et al.

Item 1 - 9 / 9
1